Immunic (IMUX) Cash from Operations (2013 - 2026)
Immunic (IMUX) reported Cash from Operations of 17301000.0 for Q1 2026, up 20.55% on a YoY basis from 14351703.78 in Q1 2025, and up 10.27% sequentially from 19281000.0 in Q4 2025.
Immunic (IMUX) Cash from Operations (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Cash from Operations data on file, last reported at 17301000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 20.55% year-over-year to 17301000.0; the trailing twelve-month figure through Mar 2026 stood at 81331000.0 (up 1.5% YoY), and the FY2025 full-year result was 85806000.0, down 1.23% from the prior year.
- Cash from Operations advanced to 17301000.0 in Q1 2026, from 19281000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 13596000.0 in Q3 2022 to a low of 24609000.0 in Q2 2025.
- A 5-year average of 19049705.88 and a median of 19513000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations soared 45.65% in 2022 and slumped 63.71% in 2024, its largest moves.
- Tracing IMUX's Cash from Operations over 5 years: stood at 15104000.0 in 2022, then grew by 7.13% to 14027000.0 in 2023, then tumbled by 63.71% to 22963000.0 in 2024, then climbed by 16.03% to 19281000.0 in 2025, then climbed by 10.27% to 17301000.0 in 2026.
- Business Quant data shows IMUX's Cash from Operations at 17301000.0 in Q1 2026, 19281000.0 in Q4 2025, and 20140000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | -17.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.30 Mn |
| Mar 31, 2026 | -17.30 Mn |
| Dec 31, 2025 | -19.28 Mn |
| Dec 31, 2025 | -19.28 Mn |
| Sep 30, 2025 | -20.14 Mn |
| Sep 30, 2025 | -20.14 Mn |
| Jun 30, 2025 | -24.61 Mn |
| Jun 30, 2025 | -24.61 Mn |
| Mar 31, 2025 | -21.78 Mn |
| Mar 31, 2025 | -21.78 Mn |
| Dec 31, 2024 | -22.96 Mn |
| Dec 31, 2024 | -22.96 Mn |
| Sep 30, 2024 | -20.80 Mn |
| Sep 30, 2024 | -20.80 Mn |
| Jun 30, 2024 | -17.04 Mn |
| Jun 30, 2024 | -17.04 Mn |
| Mar 31, 2024 | -23.97 Mn |
| Mar 31, 2024 | -23.97 Mn |
| Dec 31, 2023 | -14.03 Mn |
| Dec 31, 2023 | -14.03 Mn |